Relieving exertional dyspnea during the 3-min constant speed shuttle test in patients with COPD with indacaterol/glycopyrronium versus tiotropium: the RED trial
J Beaulieu, D Jensen, DE O'Donnell… - Therapeutic …, 2020 - journals.sagepub.com
Background: Exertional dyspnea is a cardinal feature of chronic obstructive pulmonary
disease (COPD) and a major cause of activity limitation. Although dual bronchodilation is …
disease (COPD) and a major cause of activity limitation. Although dual bronchodilation is …
The contribution of FEV1 and airflow limitation on the intensity of dyspnea and leg effort during exercise. Insights from a real‐world cohort
Rationale The effort required to cycle and breathe intensify as power increases during
incremental exercise. It is currently unclear how changes in FEV1 in the presence or …
incremental exercise. It is currently unclear how changes in FEV1 in the presence or …
[PDF][PDF] 双长效支气管扩张剂在慢性阻塞性肺疾病治疗中的研究进展
李倩， 毛山 - 世界临床药物, 2020 - jwph.com.cn
长效支气管扩张剂是稳定期慢性阻塞性肺疾病(chronic obstructive pulmonary disease, COPD)
治疗的基石. 固定剂量长效β2 受体激动剂(long acting β2 agonist, LABA)/长效抗胆碱能药物 …
治疗的基石. 固定剂量长效β2 受体激动剂(long acting β2 agonist, LABA)/长效抗胆碱能药物 …
Pharmacotherapy of LAMA/LABA inhaled therapy combinations for chronic obstructive pulmonary disease: a clinical overview
MG Matera, B Rinaldi, C Belardo… - Expert Review of Clinical …, 2022 - Taylor & Francis
Introduction Long-acting muscarinic receptor antagonist (LAMA)/β2-agonist (LABA)
combinations represent a significant improvement in the treatment of chronic obstructive …
combinations represent a significant improvement in the treatment of chronic obstructive …
Physical functioning in patients with chronic obstructive pulmonary disease treated with tiotropium/olodaterol Respimat in routine clinical practice in Italy
M Carone, A Pennisi, M D'Amato, AF Donati, A Ricci… - Pulmonary …, 2020 - Springer
Introduction Clinical studies have shown significant improvements in exercise capacity in
patients with chronic obstructive pulmonary disease (COPD) who are treated with a …
patients with chronic obstructive pulmonary disease (COPD) who are treated with a …
Какой бронходилататор выбрать, если пациент с хронической обструктивной болезнью легких продолжает курить?
ВИ Купаев, ДА Осипов - Пульмонология, 2021 - journal.pulmonology.ru
Аннотация По данным большей части публикаций, касающихся терапии хронической
обструктивной болезни легких (ХОБЛ), курящие пациенты в отдельную группу не …
обструктивной болезни легких (ХОБЛ), курящие пациенты в отдельную группу не …
The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD: current evidence and future prospects
E Derom, GG Brusselle… - Therapeutic Advances in …, 2019 - journals.sagepub.com
Long-acting bronchodilators are the cornerstone of pharmacologic treatment of chronic
obstructive pulmonary disease (COPD). Spiolto® or Stiolto® is a fixed-dose combination …
obstructive pulmonary disease (COPD). Spiolto® or Stiolto® is a fixed-dose combination …
Assessment of physical functioning in patients with chronic obstructive pulmonary disease (COPD) requiring long-acting dual bronchodilation in routine clinical …
JM París, PMA Hernández, JAD García… - Medicina de Familia …, 2021 - Elsevier
Objective We aim to determine the effect of a fixed-dose combination (FDC) of
tiotropium/olodaterol on Physical activity (PA) in patients with chronic obstructive pulmonary …
tiotropium/olodaterol on Physical activity (PA) in patients with chronic obstructive pulmonary …
[HTML][HTML] Predicting the rate of oxygen consumption during the 3-minute constant-rate stair stepping and shuttle tests in people with chronic obstructive pulmonary …
H Lewthwaite, EM Koch, M Ekström… - Journal of Thoracic …, 2020 - ncbi.nlm.nih.gov
Background The 3-minute constant-rate stair stepping (3-min CRSST) and constant-speed
shuttle tests (3-min CSST) were developed to assess breathlessness in response to a …
shuttle tests (3-min CSST) were developed to assess breathlessness in response to a …
[PDF][PDF] LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
M Miravitlles Fernández, T Kawayama, M Dreher - 2022 - scientiasalut.gencat.cat
Inhaled bronchodilators (alone or in combination) are the cornerstone of treatment for
symptomatic patients with COPD, either as initial/first-line treatment or for second …
symptomatic patients with COPD, either as initial/first-line treatment or for second …